Valuation : Celltrion, Inc.

Market Cap 43,944B 32.79B 28.22B 26.57B 24.21B 45.3B 3,120B 45.48B 315B 122B 1,590B 123B 120B 5,036B P/E 2026 *
27.8x
P/E 2027 * 23.8x
Enterprise Value 46.16B 34.44M 29.64M 27.91M 25.43M 47.58M 3.28B 47.77M 331M 128M 1.67B 129M 127M 5.29B EV / Sales 2026 *
8.36x
EV / Sales 2027 * 7.15x
Free-Float
60.59%
Yield 2026 *
0.41%
Yield 2027 * 0.45%
1 week-2.61%
Current month-3.07%
1 month-8.13%
3 months+14.87%
6 months-9.53%
Current year+6.22%
1 week 181,500
Extreme 181500
191,100
1 month 181,500
Extreme 181500
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.61%+13.09%+42.33% 32.75B
-3.24%-6.89%-5.65%+11.20% 48.01B
+0.17%-0.74%+407.28%+531.82% 44.44B
-0.86%-2.60%+35.51%+19.34% 42.67B
-0.14%-2.98%-0.04%+67.75% 39.96B
-3.44%-2.43% - - 17.74B
-0.78%-1.13%+20.74%+109.88% 16.49B
-0.37%-0.87%+10.98%+30.93% 14.38B
-0.86%-4.60%+76.86%+39.41% 13.4B
+0.74%-0.21%-5.58%-37.56% 12.22B
Average -0.83%-0.67%+61.47%+90.57% 28.21B
Weighted average by Cap. -0.88%-1.14%+80.33%+118.86%

Financials

2026 *2027 *
Net sales 5,518B 4.12B 3.54B 3.34B 3.04B 5.69B 392B 5.71B 39.54B 15.28B 200B 15.46B 15.13B 632B 6,337B 4.73B 4.07B 3.83B 3.49B 6.53B 450B 6.56B 45.41B 17.55B 229B 17.76B 17.37B 726B
Net income 1,536B 1.15B 986M 928M 846M 1.58B 109B 1.59B 11B 4.25B 55.55B 4.3B 4.21B 176B 1,785B 1.33B 1.15B 1.08B 983M 1.84B 127B 1.85B 12.79B 4.94B 64.57B 5B 4.89B 205B
Net Debt 2,215B 1.65B 1.42B 1.34B 1.22B 2.28B 157B 2.29B 15.87B 6.13B 80.11B 6.21B 6.07B 254B 1,355B 1.01B 870M 819M 746M 1.4B 96.21B 1.4B 9.71B 3.75B 49.02B 3.8B 3.71B 155B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-08 183,100.00 0.00% 372,393
26-09-08 ₩183,100.00 -1.72% 482,451
26-09-07 ₩186,300.00 -0.96% 408,399
26-09-04 ₩188,100.00 +0.53% 270,580
26-09-03 ₩187,100.00 +0.43% 406,507
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
183,100.00KRW
Average target price
268,232.21KRW
Spread / Average Target
+46.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!